More news on this day
Recent Marburg virus outbreaks in East Africa, most recently in Ethiopia from late 2025 to early 2026, are prompting renewed health alerts for international travelers even as local authorities declare the events over and global agencies emphasize the continuing risk of future flare-ups.
Get the latest news straight to your inbox!
Latest Marburg Developments and Why Travelers Are on Alert
Publicly available information from the World Health Organization, the Africa Centres for Disease Control and Prevention, and national ministries of health indicates that Ethiopia’s first documented Marburg virus outbreak ran from November 2025 until it was declared over on January 26, 2026, after 42 days without new confirmed cases. Reports describe at least 14 confirmed infections and multiple deaths in the southern Omo region near the border with South Sudan, with several health workers among those affected.
Earlier events demonstrate how quickly the virus can surface in new areas. Tanzania reported a Marburg outbreak in its Kagera region in early 2025, ultimately confirming a limited number of cases and deaths before announcing the end of transmission in March 2025. These followed earlier Marburg emergencies in Equatorial Guinea and Tanzania in 2023, as well as outbreaks in Ghana, Guinea, Uganda, Angola, the Democratic Republic of the Congo, Kenya, Rwanda and South Africa over the past two decades.
While current assessments from agencies such as the United States Centers for Disease Control and Prevention describe the present risk to travelers in countries like the United States as low, the appearance of Marburg in new locations over recent years has triggered a series of travel health notices and operational alerts for airlines, airports and cross-border transport hubs. The pattern underscores that even after official declarations that specific outbreaks have ended, vigilance remains critical for regions connected by frequent air travel.
For international travelers, the main concern is not widespread community transmission in distant countries but the possibility of localized clusters in areas with limited health-system capacity, which can create rapid-onset complications for those moving through affected regions or returning home after exposure.
Understanding Marburg Virus and How It Spreads Across Borders
Marburg virus disease is a rare but highly lethal viral hemorrhagic fever related to Ebola. Public health summaries describe case-fatality rates that have ranged from roughly one quarter to more than three quarters of reported patients in past outbreaks, depending on the setting and speed of clinical care. The virus is believed to originate in certain fruit bat species and can spill over to humans in caves, mines or other bat habitats.
Once in humans, Marburg spreads primarily through direct contact with blood or other bodily fluids of an infected person, or with contaminated surfaces, clothing or bedding. Unlike respiratory diseases such as COVID-19 or influenza, Marburg is not considered airborne in routine circumstances. Nevertheless, close physical proximity without protective equipment, especially in health care settings or during traditional burial practices, has repeatedly been linked to chains of transmission.
International movement becomes a concern when individuals incubating the virus travel while still asymptomatic, then develop signs of illness after crossing borders. Historical case reports compiled by global health agencies show that travel-related Marburg infections have occasionally been detected among people who visited caves or mines in endemic regions and later became ill in other countries. These episodes have typically been contained through rapid isolation and contact tracing, but they illustrate how a localized outbreak can have global implications.
Because Marburg’s early symptoms, such as fever, headache, muscle pain and gastrointestinal upset, overlap with far more common infections like malaria or foodborne illness, detection can be challenging without specific diagnostic testing. This overlap is one of the reasons travel and aviation authorities treat any suspected Marburg exposure seriously, even when the overall likelihood of infection is low.
Current Travel Advisories, Screening Practices and Airline Responses
In response to the Ethiopia outbreak, CDC issued a Level 1 Travel Health Notice for the country in November 2025, advising travelers to practice usual precautions while staying informed about local health developments. Publicly available summaries emphasize that widespread travel bans were not recommended; instead, the focus has been on targeted risk communication, surveillance and preparedness in affected regions and key transit points.
Reports from previous Marburg emergencies in Equatorial Guinea, Tanzania and other nations outline a similar pattern. Rather than imposing broad restrictions, international health bodies have generally recommended exit screening for symptomatic travelers where resources permit, enhanced infection prevention measures at hospitals, and rapid reporting of suspected cases through established surveillance networks. Neighboring countries are typically urged to strengthen preparedness at land borders, seaports and international airports.
Airlines and airport operators adapt their procedures in line with this guidance. Public information describes steps such as reinforcing cabin crew training to recognize signs of severe infectious illness, reviewing protocols for isolating and managing an ill passenger on board, and coordinating with ground medical teams upon landing. Some carriers flying to or from regions affected by Marburg or other viral hemorrhagic fevers also revisit cleaning and disinfection routines for aircraft and terminal areas during heightened alert periods.
For travelers, this environment may translate into more visible health messaging in terminals, routine exit or entry questions about recent symptoms and exposures, and occasional delays when a passenger becomes ill in transit. While such measures can inconvenience itineraries, they are designed to keep individual risk low and prevent small clusters from seeding larger cross-border events.
Practical Guidance for Travelers Heading to or From Affected Regions
Health agencies stress that most international travelers, including those passing through major African hubs, face a very low likelihood of encountering Marburg virus. Even so, the latest advisories highlight several practical steps that can further reduce risk. Travelers are urged to check the most recent travel health notices for their destination, monitor updates from reputable public health institutions, and consult a travel medicine clinic well in advance of departure when visiting remote or high-risk areas.
On the ground, people are encouraged to avoid direct contact with anyone who appears seriously ill, particularly if they show signs of severe fever, persistent vomiting or unexplained bleeding. Travelers are also advised to refrain from entering caves or mines that host large bat colonies, to use good hand hygiene with soap and water or alcohol-based sanitizer, and to take additional precautions if visiting health care facilities where viral hemorrhagic fevers are being treated.
Those returning from regions that have recently reported Marburg cases are generally asked to monitor their health for several weeks, in line with typical incubation periods described in technical guidance. Anyone who develops sudden fever, muscle aches or gastrointestinal symptoms after such travel is urged by public health messaging to seek medical care promptly, specifying their travel history so clinicians can consider rare but serious infections alongside more common diagnoses.
Travel insurance providers and tour operators increasingly incorporate epidemic and outbreak clauses into their terms. Travelers may benefit from reviewing these provisions carefully, ensuring that coverage includes medical evacuation and emergency care in settings where specialized treatment for viral hemorrhagic fevers might not be readily available.
Long-Term Outlook for Global Travel and Marburg Preparedness
The end of the 2025–26 Ethiopia Marburg outbreak, following earlier events in Tanzania and Equatorial Guinea, illustrates both progress and continuing vulnerability. Public data show that rapid laboratory confirmation, coordinated field investigation, and community engagement can interrupt transmission in a matter of weeks, even in regions with significant resource constraints.
At the same time, the geographic spread of Marburg appearances in recent decades suggests that future flare-ups are likely, especially in areas where human activities intersect closely with bat habitats and where health systems face persistent strain. International travel networks mean that any such outbreak can quickly become a matter of concern far beyond national borders, even if actual case numbers remain small and localized.
For the global travel sector, the experience of managing Marburg alerts feeds into broader pandemic preparedness planning. Airlines, airports and tourism operators increasingly integrate scenario planning for rare but high-consequence pathogens into their risk assessments, building on lessons learned from Ebola, COVID-19 and now a series of Marburg events. These efforts are intended to support continuity of travel while ensuring that early warning signs are not missed.
For travelers, the message emerging from current Marburg-related guidance is not to avoid entire regions indefinitely, but to stay informed, follow sensible health precautions and remain alert to evolving advisories. In a world of dense flight connections and dynamic disease patterns, informed decision-making and flexible planning have become essential parts of international travel.